documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
2,899 rows where document_type = "Notice" and posted_year = 2026 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA-R01-SFUND-2026-0826-0001 | EPA | Savage Municipal OU1 Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2026-0826 | DRAFT THIRD EXPLANATION OF SIGNIFICANT DIFFERENCES (ESD) - OPERABLE UNIT (OU) 1 FOR PUBLIC COMMENT | Notice | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T04:00:00Z | 2026-05-31T03:59:59Z | 2026-05-15T17:14:22Z | 1 | 0 | 09000064b92d8fff | ||
| EPA_FRDOC_0001-32815 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Environmental Impact Statements; Availability, etc. | Notice | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T04:00:00Z | 2026-05-15T16:06:05Z | 2026-09788 | 0 | 0 | 09000064b92da963 | ||
| FDA-2025-N-0421-0002 | FDA | NOOH Proposal to Debar Oscar Bobo FDA-2025-N-0421 | Oscar Bobo: Final Debarment Order | Notice | Statutory Debarment | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T04:00:00Z | 2026-05-15T17:48:54Z | 2026-09767 | 1 | 0 | 09000064b92da9bd | |
| FWS-HQ-IA-2026-1915-0001 | FWS | Agency Information Collection Activities; Submission to the Office of Management and Budget; Federal Fish and Wildlife Permit Applications and Reports—Management Authority FWS-HQ-IA-2026-1915 | Agency Information Collection Activities; Submission to the Office of Management and Budget; Federal Fish and Wildlife Permit Applications and Reports-Management Authority | Notice | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T04:00:00Z | 2026-05-15T16:50:38Z | 2026-09805 | 0 | 0 | 09000064b92da383 | ||
| FWS-R5-FAC-2026-1684-0001 | FWS | Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs FWS-R5-FAC-2026-1684 | Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs | Notice | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T16:47:48Z | 2026-09751 | 0 | 0 | 09000064b92da381 | |||
| FWS-HQ-IA-2026-0298-0001 | FWS | Receipt of Application Minnesota Zoo, PER26188753 FWS-HQ-IA-2026-0298 | Foreign Endangered Species; Receipt of Permit Applications | Notice | 2026-05-15T04:00:00Z | 2026 | 5 | 2026-05-15T04:00:00Z | 2026-06-16T03:59:59Z | 2026-05-15T16:53:53Z | 2026-09807 | 1 | 0 | 09000064b92db145 | |
| APHIS-2026-0101-0001 | APHIS | 2) General Conference Committee of the National Poultry Improvement Plan; Solicitation for Membership APHIS-2026-0101 | Requests for Nominations: General Conference Committee of the National Poultry Improvement Plan | Notice | Notice of Conference | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T04:00:00Z | 2026-05-14T16:55:24Z | 2026-09695 | 0 | 0 | 09000064b92d8242 | |
| APHIS-2026-0496-0001 | APHIS | Notice of Request for Revision to and Extension of Approval of an Information Collection; Restrictions on Importation of Live Poultry, Poultry Meat, and Other Poultry Products from Specified Regions. APHIS-2026-0496 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Restrictions on Importation of Live Poultry, Poultry Meat, and Other Poultry Products from Specified Regions | Notice | Information Collection Request (ICR) | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T04:00:00Z | 2026-07-14T03:59:59Z | 2026-05-14T17:02:55Z | 2026-09639 | 1 | 0 | 09000064b92d74a2 |
| EPA-R09-OAR-2025-0454-0026 | EPA | Draft Tribal Minor NSR Permit for Jamul Casino Resort EPA-R09-OAR-2025-0454 | Permits; Applications, Issuances, etc.: Jamul Casino Resort, Clean Air Act Tribal Minor New Source Review | Notice | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T04:00:00Z | 2026-05-14T21:56:52Z | 2026-09588 | 0 | 0 | 09000064b92d4a5b | ||
| EPA_FRDOC_0001-32804 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Draft Fiscal Year 2027 Evidence Plan | Notice | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T04:00:00Z | 2026-05-29T03:59:59Z | 2026-05-14T16:25:42Z | 2026-09586 | 1 | 0 | 09000064b92d74d0 | |
| EPA_FRDOC_0001-32807 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Proposed Settlement Agreement, Stipulation, Order, and Judgment, etc.: CERCLA; Cost Recovery for the Desha Road Superfund Site, Tappahannock, Essex County, VA | Notice | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T04:00:00Z | 2026-06-16T03:59:59Z | 2026-05-14T16:26:15Z | 2026-09587 | 1 | 0 | 09000064b92d8203 | |
| EPA_FRDOC_0001-32810 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Hearings, Meetings, Proceedings, etc.: Ozone Transport Commission and the Mid-Atlantic Northeast Visibility Union | Notice | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T04:00:00Z | 2026-05-14T16:26:22Z | 2026-09585 | 0 | 0 | 09000064b92d8248 | ||
| USDA_FRDOC_0001-3306 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-05-14T04:00:00Z | 2026 | 5 | 2026-05-14T04:00:00Z | 2026-05-14T16:26:14Z | 2026-09645 | 0 | 0 | 09000064b92d8201 | ||
| APHIS-2026-0431-0001 | APHIS | Notice of Request for Extension of Approval of an Information Collection; Federally Recognized State Managed Phytosanitary Program APHIS-2026-0431 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Federally Recognized State Managed Phytosanitary Program | Notice | Information Collection Request (ICR) | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T04:00:00Z | 2026-07-14T03:59:59Z | 2026-05-13T17:08:42Z | 2026-09519 | 1 | 0 | 09000064b92d4a1a |
| FDA-2026-N-4126-0001 | FDA | Azodicarbonamide (ADA); Request for Information FDA-2026-N-4126 | Azodicarbonamide (ADA); Request for Information | Notice | Requests for Information (RFI) | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T04:00:00Z | 2026-07-14T03:59:59Z | 2026-05-13T17:13:38Z | 2026-09508 | 1 | 0 | 09000064b92d17fd |
| FDA-2026-N-3098-0001 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting FDA-2026-N-3098 | Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting | Notice | 60 Day Proposed Information Collection | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T04:00:00Z | 2026-07-14T03:59:59Z | 2026-05-13T16:56:28Z | 2026-09543 | 1 | 0 | 09000064b92d4966 |
| FDA-2026-N-2526-0001 | FDA | Butylated hydroxytoluene (BHT); Request for Information FDA-2026-N-2526 | Butylated Hydroxytoluene (BHT); Request for Information | Notice | Requests for Information (RFI) | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T04:00:00Z | 2026-07-14T03:59:59Z | 2026-05-13T17:01:00Z | 2026-09507 | 1 | 0 | 09000064b92d4931 |
| FDA-2019-N-0994-0230 | FDA | Modified Risk Tobacco Product Applications for VLN™ King and VLN™ Menthol King, Combusted, Filtered Cigarettes, Submitted by 22nd Century Group Inc. FDA-2019-N-0994 | Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc. | Notice | Request for Comments | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T04:00:00Z | 2026-05-15T09:00:24Z | 2026-09544 | 1 | 0 | 09000064b92d47df | |
| FDA-2025-N-1600-0003 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 FDA-2025-N-1600 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3 | Notice | 30 Day Proposed Information Collection | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T04:00:00Z | 2026-06-13T03:59:59Z | 2026-05-13T17:17:21Z | 2026-09448 | 1 | 0 | 09000064b92d4828 |
| FDA-2026-N-0005-0001 | FDA | Public Seminar FDA-2026-N-0005 | Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information | Notice | Requests for Information (RFI) | 2026-05-13T04:00:00Z | 2026 | 5 | 2026-05-13T04:00:00Z | 2026-07-14T03:59:59Z | 2026-05-13T17:06:21Z | 2026-09533 | 1 | 0 | 09000064b92d48f3 |
| EPA-HQ-OPPT-2003-0004-0151 | EPA | Access to TSCA Confidential Business Information (CBI) EPA-HQ-OPPT-2003-0004 | Access to Confidential Business Information: Science Applications International Corp. | Notice | 2026-05-12T04:00:00Z | 2026 | 5 | 2026-05-12T18:23:59Z | 2026-09370 | 0 | 0 | 09000064b92d164d | |||
| FDA-2026-N-4492-0001 | FDA | Drug Repurposing for Unmet Medical Needs; Request for Information FDA-2026-N-4492 | Drug Repurposing for Unmet Medical Needs; Request for Information | Notice | Requests for Information (RFI) | 2026-05-12T04:00:00Z | 2026 | 5 | 2026-05-12T04:00:00Z | 2026-06-12T03:59:59Z | 2026-05-15T09:00:24Z | 2026-09366 | 1 | 0 | 09000064b92d15f4 |
| FDA-2017-N-5925-0040 | FDA | Standard Development Organizations Whose Susceptibility Test Interpretive Criteria Standards May Be Recognized by FDA FDA-2017-N-5925 | 21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria web page | Notice | Request for Comments | 2026-05-12T04:00:00Z | 2026 | 5 | 2026-05-12T04:00:00Z | 2026-05-12T22:58:36Z | 2026-09438 | 1 | 0 | 09000064b92d17af | |
| FDA-2026-D-5083-0001 | FDA | Enforcement Policies for Certain Electronic Nicotine Delivery Systems (ENDS) Marketed Without Premarket Authorization; Guidance for Industry; Availability FDA-2026-D-5083 | Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability | Notice | Notice of Availability | 2026-05-12T04:00:00Z | 2026 | 5 | 2026-05-12T04:00:00Z | 2026-05-12T17:17:05Z | 2026-09368 | 0 | 0 | 09000064b92d1762 | |
| FDA-2025-N-2220-0002 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products FDA-2025-N-2220 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products | Notice | 30 Day Proposed Information Collection | 2026-05-11T04:00:00Z | 2026 | 5 | 2026-05-11T04:00:00Z | 2026-06-11T03:59:59Z | 2026-05-11T21:25:31Z | 2026-09244 | 1 | 0 | 09000064b92cfa18 |
| FDA-2011-N-0655-0042 | FDA | Animal Generic Drug User Fee Act; Public Meeting FDA-2011-N-0655 | Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate | Notice | Notice of Intent | 2026-05-11T04:00:00Z | 2026 | 5 | 2026-05-11T04:00:00Z | 2026-05-11T21:26:21Z | 2026-09284 | 0 | 0 | 09000064b92cf91b | |
| FDA-2026-N-4573-0001 | FDA | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm) FDA-2026-N-4573 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm) | Notice | Announcement | 2026-05-11T04:00:00Z | 2026 | 5 | 2026-05-11T04:00:00Z | 2026-05-11T17:34:15Z | 2026-09242 | 0 | 0 | 09000064b92cf987 | |
| FDA-2013-D-1319-0015 | FDA | Draft Guidance for Industry on Pulmonary Tuberculosis: Developing Drugs for Treatment; Availability FDA-2013-D-1319 | Pulmonary Tuberculosis: Developing Drugs for Treatment; Guidance for Industry; Availability | Notice | Notice of Availability | 2026-05-11T04:00:00Z | 2026 | 5 | 2026-05-11T04:00:00Z | 2026-05-11T17:27:37Z | 2026-09269 | 0 | 0 | 09000064b92cf98a | |
| FDA-2018-D-4693-0022 | FDA | Postapproval Pregnancy Safety Studies; Draft Guidance for Industry; Availability FDA-2018-D-4693 | Postapproval Pregnancy Safety Studies; Guidance for Industry; Availability | Notice | Notice of Availability | 2026-05-11T04:00:00Z | 2026 | 5 | 2026-05-11T04:00:00Z | 2026-05-11T17:36:17Z | 2026-09268 | 0 | 0 | 09000064b92cf982 | |
| FDA-2011-N-0656-1315 | FDA | Animal Drug User Fee Act; Public Meeting FDA-2011-N-0656 | Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate | Notice | General Notice | 2026-05-11T04:00:00Z | 2026 | 5 | 2026-05-11T04:00:00Z | 2026-05-11T17:56:32Z | 2026-09283 | 0 | 0 | 09000064b92cacd0 | |
| FDA-2022-D-1261-0003 | FDA | Clostridioides difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, and Prevention; Draft Guidance for Industry; Availability FDA-2022-D-1261 | Clostridioides Difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, or Prevention; Guidance for Industry; Availability | Notice | Notice of Availability | 2026-05-11T04:00:00Z | 2026 | 5 | 2026-05-11T04:00:00Z | 2026-05-11T17:42:11Z | 2026-09267 | 0 | 0 | 09000064b92cf922 | |
| FWS-HQ-IA-2026-0760-0001 | FWS | Receipt of Application Carolina Tiger Rescue FWS-HQ-IA-2026-0760 | Foreign Endangered Species; Receipt of Permit Applications | Notice | 2026-05-11T04:00:00Z | 2026 | 5 | 2026-05-11T04:00:00Z | 2026-06-11T03:59:59Z | 2026-05-11T17:39:40Z | 2026-09233 | 1 | 0 | 09000064b92cf3d8 | |
| FWS-HQ-IA-2026-1057-0001 | FWS | Receipt of Application Tanganyika Wildlife Preserve dba Tanganyika Wildlife Park, Permit No. PER23008706 FWS-HQ-IA-2026-1057 | Foreign Endangered Species; Receipt of Permit Applications | Notice | 2026-05-11T04:00:00Z | 2026 | 5 | 2026-05-11T04:00:00Z | 2026-06-11T03:59:59Z | 2026-05-13T09:00:30Z | 2026-09234 | 1 | 0 | 09000064b92cf3d5 | |
| EPA_FRDOC_0001-32797 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Environmental Impact Statements; Availability, etc. | Notice | 2026-05-08T04:00:00Z | 2026 | 5 | 2026-05-08T04:00:00Z | 2026-05-08T16:25:27Z | 2026-09180 | 0 | 0 | 09000064b92c962b | ||
| FDA-2026-P-0749-0004 | FDA | Requests that the FDA determine whether Leucovorin Calcium For Oral Solution, EQ 60 mg base/vial, (NDA 008107) held by Hospira Inc. has been voluntarily withdrawn or withheld from sale for reasons of safety or efficacy FDA-2026-P-0749 | Determination That Leucovorin Calcium, Oral Solution, Equivalent to 60 Milligrams Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2026-05-08T04:00:00Z | 2026 | 5 | 2026-05-08T17:04:13Z | 2026-09199 | 0 | 0 | 09000064b92c97d0 | ||
| EPA-R03-OW-2025-2004-0006 | EPA | Virginia - Waters of the Northern Neck Peninsula Vessel Sewage No-Discharge Zone EPA-R03-OW-2025-2004 | Final Affirmative Determination: Virginia; Waters of the Northern Neck Peninsula Vessel Sewage No-Discharge Zone | Notice | 2026-05-07T04:00:00Z | 2026 | 5 | 2026-05-07T04:00:00Z | 2026-05-07T17:34:41Z | 2026-09042 | 0 | 0 | 09000064b92c865f | ||
| EPA_FRDOC_0001-32793 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Clean Air Act Operating Permit Program: Order on Petitions for Objection to State Operating Permits for Bargath, LLC's Clough, Heath, Hyrup, Jangles and Starkey Gulch Compressor Stations, and Grand River Gathering, LLC's East Mamm Creek Compressor Station | Notice | 2026-05-07T04:00:00Z | 2026 | 5 | 2026-05-07T04:00:00Z | 2026-05-07T16:26:20Z | 2026-09053 | 0 | 0 | 09000064b92c861b | ||
| EPA-R01-SFUND-2025-3126-0001 | EPA | Callahan Mine - Draft Explanation of Significant Differences (ESD) EPA-R01-SFUND-2025-3126 | DRAFT THIRD EXPLANATION OF SIGNIFICANT DIFFERENCES (ESD) - OPERABLE UNIT (OU) 3 FOR PUBLIC COMMENT | Notice | 2026-05-07T04:00:00Z | 2026 | 5 | 2026-05-07T04:00:00Z | 2026-05-19T03:59:59Z | 2026-05-07T22:10:10Z | 1 | 0 | 09000064b9284542 | ||
| FDA-2025-P-7054-0006 | FDA | Request that the FDA determine whether the Reference Listed Drug (RLD) MICARDIS (Telmisartan Tablets, 20 mg and 80 mg) under New Drug Application (NDA) N020850 held by Boehringer Ingelheim, was voluntarily withdrawn from commercial distribution or withdrawn from sale for safety or efficacy reasons FDA-2025-P-7054 | Determination That MICARDIS (Telmisartan), Tablets, 20 Milligrams and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2026-05-07T04:00:00Z | 2026 | 5 | 2026-05-07T04:00:00Z | 2026-05-07T17:15:35Z | 2026-09011 | 0 | 0 | 09000064b92c66bf | |
| FDA-2023-D-2370-0007 | FDA | Patient-Matched Guides to Orthopedic Implants; Draft Guidance for Industry and Food and Drug Administration Staff; Draft Guidance for Industry and Food and Drug Administration Staff; Availability FDA-2023-D-2370 | Patient-Matched Guides for Orthopedic Implants; Guidance for Industry and Food and Drug Administration Staff; Availability | Notice | Notice of Availability | 2026-05-07T04:00:00Z | 2026 | 5 | 2026-05-07T04:00:00Z | 2026-05-07T17:05:32Z | 2026-09023 | 0 | 0 | 09000064b92c78fc | |
| FDA-2026-N-4291-0001 | FDA | Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications FDA-2026-N-4291 | Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications | Notice | Withdrawal | 2026-05-07T04:00:00Z | 2026 | 5 | 2026-05-07T04:00:00Z | 2026-05-07T16:54:25Z | 2026-09012 | 0 | 0 | 09000064b92c85aa | |
| FDA-2026-N-0008-0004 | FDA | Advisory Committee FDA-2026-N-0008 | Advisory Committee; Blood Products Advisory Committee; Renewal | Notice | Notice of Renewal | 2026-05-07T04:00:00Z | 2026 | 5 | 2026-05-07T04:00:00Z | 2026-05-07T17:02:15Z | 2026-09108 | 0 | 0 | 09000064b92c85a3 | |
| FWS-R4-ES-2026-0727-0001 | FWS | Receipt of Incidental Take Permit Application and Proposed Habitat Conservation Plan for Sand Skink and Blue-tailed Mole Skink; Polk County, FL; Categorical Exclusion (applicant: FLLWCC, LLC / FLOW CC, LLC) FWS-R4-ES-2026-0727 | Receipt of Incidental Take Permit Application and Proposed Habitat Conservation Plan for Sand Skink and Blue-tailed Mole Skink; Polk County, FL; Categorical Exclusion (applicant: FLLWCC, LLC / FLOW CC, LLC) | Notice | 2026-05-07T04:00:00Z | 2026 | 5 | 2026-05-07T04:00:00Z | 2026-06-09T03:59:59Z | 2026-05-07T15:32:32Z | 2026-09093 | 1 | 0 | 09000064b92c7747 | |
| EPA-HQ-OPP-2025-3951-0001 | EPA | Experimental Use Permit for Wolbachia pipientis wAlbB Contained in Live Adult Culex quinquefasciatus Male Mosquitoes (DQB Strain) EPA-HQ-OPP-2025-3951 | Permits; Applications, Issuances, etc.: Pesticide Experimental Use | Notice | 2026-05-06T04:00:00Z | 2026 | 5 | 2026-05-06T04:00:00Z | 2026-06-06T03:59:59Z | 2026-05-16T12:32:23Z | 2026-08808 | 1 | 0 | 09000064b92c5b51 | |
| FDA-2026-N-4588-0001 | FDA | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; OTARMENI (lunsotogene parvec-cwha) FDA-2026-N-4588 | Issuance of Priority Review Voucher; Rare Pediatric Disease Product; OTARMENI (lunsotogene parvec-cwha) | Notice | Announcement | 2026-05-06T04:00:00Z | 2026 | 5 | 2026-05-06T04:00:00Z | 2026-05-06T17:40:41Z | 2026-08913 | 0 | 0 | 09000064b92c5bca | |
| FDA-2026-P-1306-0004 | FDA | Requests that the FDA to determine whether the Reference Listed Drug (RLD) DEXAMETHASONE ELIXIR, 0.5 mg/5 mL; Abbreviated New Drug Application (ANDA) 088254 of PHARMOBEDIENT CONSULTING has been voluntarily withdrawn from sale for safety or efficacy reasons. FDA-2026-P-1306 | Determination That DEXAMETHASONE (Dexamethasone) Elixir, 0.5 Milligrams/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2026-05-06T04:00:00Z | 2026 | 5 | 2026-05-06T04:00:00Z | 2026-05-06T17:34:01Z | 2026-08939 | 0 | 0 | 09000064b92c65a4 | |
| FWS-R1-ES-2026-0959-0001 | FWS | Endangered and Threatened Wildlife and Plants; Initiation of 5-Year Status Reviews for 78 Species in Hawaii, Idaho, Oregon, and California FWS-R1-ES-2026-0959 | Endangered and Threatened Wildlife and Plants; Initiation of 5-Year Status Reviews for 78 Species in Hawaii, Idaho, Oregon, and California | Notice | 2026-05-06T04:00:00Z | 2026 | 5 | 2026-05-06T04:00:00Z | 2026-07-07T03:59:59Z | 2026-05-06T15:38:11Z | 2026-08969 | 1 | 0 | 09000064b92c565c | |
| EPA-HQ-OPPT-2018-0427-0182 | EPA | 1,2-Dichloroethane; TSCA Review EPA-HQ-OPPT-2018-0427 | 1,2-Dichloroethane; Final Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Availability | Notice | Notice of Data Availability | 2026-05-05T04:00:00Z | 2026 | 5 | 2026-05-05T17:24:29Z | 2026-08682 | 0 | 0 | 09000064b92c373d | ||
| EPA-HQ-OW-2002-0059-0029 | EPA | Safe Drinking Water Act Revolving Fund Program ICR EPA-HQ-OW-2002-0059 | Proposed Information Collection Request; Clean Water State Revolving Fund and Drinking Water State Revolving Fund Programs; EPA ICR No. 1803.10, OMB Control No. 2040-0185 | Notice | Information Collection Request (ICR) | 2026-05-05T04:00:00Z | 2026 | 5 | 2026-05-05T04:00:00Z | 2026-07-07T03:59:59Z | 2026-05-06T20:13:53Z | 2026-08693 | 1 | 0 | 09000064b92c12bb |
| FWS-HQ-FAC-2026-1123-0001 | FWS | Sport Fishing and Boating Partnership Council; Call for Nominations FWS-HQ-FAC-2026-1123 | Sport Fishing and Boating Partnership Council; Call for Nominations | Notice | 2026-05-05T04:00:00Z | 2026 | 5 | 2026-05-05T18:08:52Z | 2026-08734 | 0 | 0 | 09000064b92c2665 | |||
| FDA-2026-N-3070-0001 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey FDA-2026-N-3070 | Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey | Notice | 60 Day Proposed Information Collection | 2026-05-04T04:00:00Z | 2026 | 5 | 2026-05-04T04:00:00Z | 2026-07-07T03:59:59Z | 2026-05-04T19:19:25Z | 2026-08604 | 1 | 0 | 09000064b92c115c |
| FWS-R8-ES-2025-0054-0001 | FWS | Incidental Take Permit Application for the Desert Tortoise; Draft Habitat Conservation Plan and Draft Environmental Assessment; CalPortland – Oro Grande Quarries and Cement Plant, San Bernardino County, CA FWS-R8-ES-2025-0054 | Incidental Take Permit Application for the Desert Tortoise; Draft Habitat Conservation Plan and Draft Environmental Assessment; CalPortland—Oro Grande Quarries and Cement Plant, San Bernardino County, CA | Notice | 2026-05-04T04:00:00Z | 2026 | 5 | 2026-05-04T04:00:00Z | 2026-06-04T03:59:59Z | 2026-05-05T20:22:50Z | 2026-08579 | 1 | 0 | 09000064b92c12c3 | |
| FWS-R3-ES-2026-0860-0001 | FWS | Endangered and Threatened Species; Receipt of Recovery Permit Applications (applicant: Missouri Department of Conservation, Warsaw, MO) FWS-R3-ES-2026-0860 | Endangered and Threatened Species; Receipt of Recovery Permit Applications (applicant: Missouri Department of Conservation, Warsaw, MO) | Notice | 2026-05-04T04:00:00Z | 2026 | 5 | 2026-05-04T04:00:00Z | 2026-06-04T03:59:59Z | 2026-05-05T20:23:13Z | 2026-08574 | 1 | 0 | 09000064b92be1b3 | |
| FWS-HQ-IA-2025-1441-0001 | FWS | Receipt of Application Coastal Exotics PER19299054 FWS-HQ-IA-2025-1441 | Endangered Species; Issuance of Permits (applicant: Coastal Exotics, Inc.) | Notice | 2026-05-04T04:00:00Z | 2026 | 5 | 2026-05-04T18:55:56Z | 2026-08592 | 0 | 0 | 09000064b92c04f0 | |||
| EPA_FRDOC_0001-32784 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Environmental Impact Statements; Availability, etc. | Notice | 2026-05-01T04:00:00Z | 2026 | 5 | 2026-05-01T04:00:00Z | 2026-05-01T16:25:15Z | 2026-08520 | 0 | 0 | 09000064b92bb772 | ||
| FDA-2018-N-3240-0377 | FDA | List of Bulk Drug Substances For Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Notice FDA-2018-N-3240 | List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act | Notice | Request for Comments | 2026-05-01T04:00:00Z | 2026 | 5 | 2026-05-01T04:00:00Z | 2026-07-01T03:59:59Z | 2026-05-16T09:00:17Z | 2026-08552 | 1 | 0 | 09000064b92bb724 |
| FDA-2026-N-3499-0001 | FDA | Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments FDA-2026-N-3499 | Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments | Notice | Request for Comments | 2026-05-01T04:00:00Z | 2026 | 5 | 2026-05-01T04:00:00Z | 2026-07-01T03:59:59Z | 2026-05-02T09:00:17Z | 2026-08521 | 1 | 0 | 09000064b92bb7fb |
| FDA-2026-N-3947-0001 | FDA | Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments FDA-2026-N-3947 | Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments | Notice | Request for Comments | 2026-05-01T04:00:00Z | 2026 | 5 | 2026-05-01T04:00:00Z | 2026-07-01T03:59:59Z | 2026-05-09T09:00:22Z | 2026-08524 | 1 | 0 | 09000064b92bb6d7 |
| FDA-2026-N-4268-0001 | FDA | Medical Devices; Exemptions from Premarket Notification: Certain Class II Devices; Request for Comments FDA-2026-N-4268 | Medical Devices; Exemptions From Premarket Notification: Certain Class II Devices; Request for Comments | Notice | Request for Comments | 2026-05-01T04:00:00Z | 2026 | 5 | 2026-05-01T04:00:00Z | 2026-07-01T03:59:59Z | 2026-05-09T09:00:22Z | 2026-08499 | 1 | 0 | 09000064b92bb7b3 |
| USDA_FRDOC_0001-3302 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Rescission of Final Determination: Adoption of Energy Efficiency Standards for New Construction of Department of Housing and Urban Development and Department of Agriculture Financed Housing | Notice | 2026-05-01T04:00:00Z | 2026 | 5 | 2026-05-01T04:00:00Z | 2026-05-01T16:25:16Z | 2026-08531 | 0 | 0 | 09000064b92bb7f9 | ||
| APHIS-2026-0331-0001 | APHIS | Notice of Request for Revision to and Extension of Approval of an Information Collection; Pale Cyst Nematode (PCN). APHIS-2026-0331 | Agency Information Collection Activities; Proposals, Submissions, and Approvals: Pale Cyst Nematode | Notice | Information Collection Request (ICR) | 2026-04-30T04:00:00Z | 2026 | 4 | 2026-04-30T04:00:00Z | 2026-06-30T03:59:59Z | 2026-04-30T19:42:56Z | 2026-08418 | 1 | 0 | 09000064b92b8095 |
| EPA_FRDOC_0001-32781 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Draft Fiscal Year 2027 Evidence Plan | Notice | 2026-04-30T04:00:00Z | 2026 | 4 | 2026-04-30T04:00:00Z | 2026-04-30T20:46:24Z | 2026-08379 | 0 | 0 | 09000064b92b7f65 | ||
| EPA_FRDOC_0001-32782 | EPA | Recently Posted EPA Rules and Notices from FR Feed. EPA_FRDOC_0001 | Proposed Settlement Agreement, Stipulation, Order, and Judgment, etc.: CERCLA; Goodrich Asbestos Superfund Site in Ottawa County, Miami, OK | Notice | 2026-04-30T04:00:00Z | 2026 | 4 | 2026-04-30T23:32:03Z | 2026-08370 | 0 | 0 | 09000064b92b7f66 | |||
| FDA-2026-P-0655-0003 | FDA | Request that the FDA determine that the listed RLD product FENOGLIDE (fenofibrate) Tablets, 40 mg and 120 mg, N022118, NDA Holder– Salix Pharmaceuticals INC, was not discontinued for safety or effectiveness reasons FDA-2026-P-0655 | Determination FENOGLIDE (Fenofibrate) Tablets, 40 Milligrams and 120 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2026-04-30T04:00:00Z | 2026 | 4 | 2026-04-30T17:56:39Z | 2026-08390 | 0 | 0 | 09000064b92b7f6c | ||
| FDA-2026-N-0499-0002 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice FDA-2026-N-0499 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice | Notice | 30 Day Proposed Information Collection | 2026-04-30T04:00:00Z | 2026 | 4 | 2026-04-30T04:00:00Z | 2026-06-02T03:59:59Z | 2026-04-30T17:46:42Z | 2026-08417 | 1 | 0 | 09000064b92b80f2 |
| FDA-2026-N-0008-0003 | FDA | Advisory Committee FDA-2026-N-0008 | Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal | Notice | Notice of Renewal | 2026-04-30T04:00:00Z | 2026 | 4 | 2026-04-30T18:03:08Z | 2026-08378 | 0 | 0 | 09000064b92b7f20 | ||
| FDA-2025-P-3849-0004 | FDA | Requests that the FDA determine whether OZEMPIC (semaglutide) Injection, 2 mg/1.5 mL (1.34 mg/mL) was withdrawn for safety or effectiveness reasons. FDA-2025-P-3849 | Determination That OZEMPIC (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | Determinations | 2026-04-30T04:00:00Z | 2026 | 4 | 2026-04-30T18:12:42Z | 2026-08435 | 0 | 0 | 09000064b92b5df8 | ||
| FDA-2026-N-3532-0001 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies FDA-2026-N-3532 | Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies | Notice | 60 Day Proposed Information Collection | 2026-04-30T04:00:00Z | 2026 | 4 | 2026-04-30T04:00:00Z | 2026-06-30T03:59:59Z | 2026-05-02T09:00:17Z | 2026-08371 | 1 | 0 | 09000064b92b7fb3 |
| FDA-2026-N-1321-0001 | FDA | ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing FDA-2026-N-1321 | ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing | Notice | Withdrawal | 2026-04-30T04:00:00Z | 2026 | 4 | 2026-04-30T04:00:00Z | 2026-06-30T03:59:59Z | 2026-05-16T09:00:16Z | 2026-08455 | 1 | 0 | 09000064b92b7e81 |
| USDA_FRDOC_0001-3301 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-04-30T04:00:00Z | 2026 | 4 | 2026-04-30T04:00:00Z | 2026-04-30T16:25:46Z | 2026-08395 | 0 | 0 | 09000064b92b7f69 | ||
| EPA-HQ-OPPT-2026-1849-0004 | EPA | Certain New Chemicals or Significant New Uses; Statements of Findings for 2026 EPA-HQ-OPPT-2026-1849 | Certain New Chemicals or Significant New Uses: Statements of Findings - February 2026 | Notice | 2026-04-29T04:00:00Z | 2026 | 4 | 2026-04-29T17:11:49Z | 2026-08340 | 0 | 0 | 09000064b92b5d06 | |||
| FDA-2026-N-4390-0001 | FDA | AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program; Request for Information FDA-2026-N-4390 | AI-Enabled Optimization of Early- Phase Clinical Trials Pilot Program; Request for Information | Notice | Requests for Information (RFI) | 2026-04-29T04:00:00Z | 2026 | 4 | 2026-04-29T04:00:00Z | 2026-05-30T03:59:59Z | 2026-05-16T12:32:04Z | 2026-08281 | 1 | 0 | 09000064b92b54c8 |
| EPA-HQ-OLEM-2020-0527-0174 | EPA | Interim Guidance on the Destruction and Disposal of Perfluoroalkyl and Polyfluoroalkyl Substances and Materials Containing Perfluoroalkyl and Polyfluoroalkyl Substances EPA-HQ-OLEM-2020-0527 | Interim PFAS Destruction and Disposal Guidance; Notice of Availability for Public Comment | Notice | Notice of Data Availability | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-06-30T03:59:59Z | 2026-05-14T09:00:29Z | 2026-08174 | 1 | 0 | 09000064b92b2330 |
| FDA-2026-N-1832-0014 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1303 - Bifidobacterium animalis subsp. lactis CGMCC5470 | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:29:48Z | 0 | 0 | 09000064b92a8cd6 | ||
| FDA-2025-N-1928-0067 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2025 FDA-2025-N-1928 | GRAS Notice (GRN) 1279 – Saccharomyces cerevisiae CCTCC M2025194 – amendments | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:24:49Z | 0 | 0 | 09000064b92a80fa | ||
| FDA-2026-N-1832-0008 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1297 - Enzyme-hydrolyzed brown rice protein - Part 3 of 3 | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:28:45Z | 0 | 0 | 09000064b92a8ccc | ||
| FDA-2025-N-1928-0066 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2025 FDA-2025-N-1928 | GRAS Notice (GRN) 1278 – Lactiplantibacillus plantarum CGMCC 6312 – amendments | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:24:47Z | 0 | 0 | 09000064b92a80f9 | ||
| FDA-2025-N-1928-0064 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2025 FDA-2025-N-1928 | GRAS Notice (GRN) 1256 – Lemna leaf protein – amendments | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:18:46Z | 0 | 0 | 09000064b92a80f7 | ||
| FDA-2026-N-1832-0007 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1297 - Enzyme-hydrolyzed brown rice protein - Part 2 of 3 | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:28:26Z | 0 | 0 | 09000064b92a8ccb | ||
| FDA-2025-N-1928-0065 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2025 FDA-2025-N-1928 | GRAS Notice (GRN) 1276 – Cellulase enzyme preparation produced by Trichoderma reesei expressing a gene encoding a cellulase from Aspergillus niger – amendments | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:24:37Z | 0 | 0 | 09000064b92a80f8 | ||
| FDA-2026-N-1832-0015 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1304 - Preparation containing at least three bacteriophages (phage) specific to Listeria spp. | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:29:52Z | 0 | 0 | 09000064b92a8cd7 | ||
| FDA-2026-N-1832-0003 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1293 - Brazzein preparation produced by Komagataella phaffii “RA-b” expressing a gene encoding for brazzein from Pentadiplandra brazzeana - Part 2 of 2 | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:27:02Z | 0 | 0 | 09000064b92a8cc6 | ||
| FDA-2026-N-1832-0005 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1295 - Brazzein preparation produced by Komagataella phaffii GS115 expressing a gene encoding for brazzein from Pentadiplandra brazzeana | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:27:45Z | 0 | 0 | 09000064b92a8cc9 | ||
| FDA-2025-N-1928-0069 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2025 FDA-2025-N-1928 | GRAS Notice (GRN) 1296 - Erythritol produced through fermentation of glucose by Yarrowia lipolytica | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:25:01Z | 0 | 0 | 09000064b92a80fc | ||
| FDA-2025-N-1928-0068 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2025 FDA-2025-N-1928 | GRAS Notice (GRN) 1292 - Citrus-derived compounded sweetener made with neohesperidin dihydrochalcone and gamma cyclodextrin | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:24:59Z | 0 | 0 | 09000064b92a80fb | ||
| FDA-2026-N-1832-0010 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1299 - 3'-Sialyllactose (3'-SL) Sodium Salt | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:29:24Z | 0 | 0 | 09000064b92a8ccf | ||
| FDA-2026-N-1832-0006 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1297 - Enzyme-hydrolyzed brown rice protein - Part 1 of 3 | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:27:58Z | 0 | 0 | 09000064b92a8cca | ||
| FDA-2026-N-1832-0012 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1301 - Algal oil (≥45% docosahexaenoic acid from Schizochytrium sp. “JDW-108”) | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:29:36Z | 0 | 0 | 09000064b92a8cd4 | ||
| FDA-2026-N-1832-0002 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1293 - Brazzein preparation produced by Komagataella phaffii “RA-b” expressing a gene encoding for brazzein from Pentadiplandra brazzeana - Part 1 of 2 | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:26:49Z | 0 | 0 | 09000064b92a8cc5 | ||
| FDA-2026-N-1832-0004 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1294 - Rebaudioside M produced by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:27:15Z | 0 | 0 | 09000064b92a8cc7 | ||
| FDA-2026-N-1832-0009 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1298 - 2'-fucosyllactose | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:29:07Z | 0 | 0 | 09000064b92a8ccd | ||
| FDA-2026-N-1832-0013 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1302 - Fermented grape pomace | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:29:44Z | 0 | 0 | 09000064b92a8cd5 | ||
| FDA-2026-N-1832-0001 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1291 - Wattle Seeds (Acacia longifolia) | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:26:31Z | 0 | 0 | 09000064b92a8cc4 | ||
| FDA-2026-N-1832-0011 | FDA | Generally Recognized as Safe (GRAS) Notices Filed in 2026 FDA-2026-N-1832 | GRAS Notice (GRN) 1300 – Zeaxanthin | Notice | General Notice | 2026-04-28T04:00:00Z | 2026 | 4 | 2026-04-28T04:00:00Z | 2026-04-28T16:29:32Z | 0 | 0 | 09000064b92a8cd1 | ||
| FDA-2022-N-0621-0003 | FDA | Advisory Committee; Anesthetic and Analgesic Drug Products Advisory Committee; Renewal FDA-2022-N-0621 | Advisory Committee; Anesthetic and Analgesic Drug Products Advisory Committee; Renewal | Notice | Renewals | 2026-04-27T04:00:00Z | 2026 | 4 | 2026-04-27T17:18:57Z | 2026-08125 | 0 | 0 | 09000064b92ad1da | ||
| FDA-2026-N-3962-0001 | FDA | Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments – United States (U.S.) 2026-2027 Formula for COVID-19 Vaccine Composition. FDA-2026-N-3962 | Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments— United States (U.S.) 2026–2027 Formula for COVID–19 Vaccine Composition | Notice | Request for Comments | 2026-04-27T04:00:00Z | 2026 | 4 | 2026-04-27T04:00:00Z | 2026-05-28T03:59:59Z | 2026-05-16T09:00:16Z | 2026-08122 | 1 | 0 | 09000064b92ad21d |
| USDA_FRDOC_0001-3300 | USDA | Recently Posted USDA Rules and Notices. USDA_FRDOC_0001 | Agency Information Collection Activities; Proposals, Submissions, and Approvals | Notice | 2026-04-27T04:00:00Z | 2026 | 4 | 2026-04-27T04:00:00Z | 2026-04-27T16:25:44Z | 2026-08124 | 0 | 0 | 09000064b92ad21e | ||
| EPA-HQ-OW-2000-0006-0001 | EPA | Notice of Intent To Develop Ambient Water Quality Criteria for Protection of Human Health - Carbofuran EPA-HQ-OW-2000-0006 | Notice of Intent To Develop Ambient Water Quality Criteria for Protection of Human Health - Arsenic, Methylmercury, and Carbofuran; Notice of Data Availability; Request for Data and Information [W-00-19-20-21-I-A-1] | Notice | Notice of Data Availability | 2026-04-24T04:00:00Z | 2026 | 4 | 2026-04-24T04:00:00Z | 2026-04-25T00:32:11Z | 00–26222 | 0 | 0 | 09000064b92a970b | |
| EPA-HQ-OW-2000-0005-0001 | EPA | Notice of Intent To Develop Ambient Water Quality Criteria for Protection of Human Health - Methylmercury EPA-HQ-OW-2000-0005 | Notice of Intent To Develop Ambient Water Quality Criteria for Protection of Human Health - Arsenic, Methylmercury, and Carbofuran; Notice of Data Availability; Request for Data and Information [W-00-19-20-21-I-A-1] | Notice | Notice of Data Availability | 2026-04-24T04:00:00Z | 2026 | 4 | 2026-04-24T04:00:00Z | 2026-04-25T00:22:31Z | 00–26222 | 0 | 0 | 09000064b92a970a | |
| EPA-HQ-OW-2000-0004-0001 | EPA | Ambient Water Quality Criteria (AWQ) for Protection of Human Health - Arsenic EPA-HQ-OW-2000-0004 | Notice of Intent To Develop Ambient Water Quality Criteria for Protection of Human Health - Arsenic, Methylmercury, and Carbofuran; Notice of Data Availability; Request for Data and Information [W-00-19-20-21-I-A-1] | Notice | Notice of Data Availability | 2026-04-24T04:00:00Z | 2026 | 4 | 2026-04-24T04:00:00Z | 2026-04-25T00:17:15Z | 00–26222 | 0 | 0 | 09000064b92a9906 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;